Infusion Technology

Pneuma Systems Infusion Technology Accepted by FDA’s Highly Selective Safer Technologies Program (STeP)

"This is a tremendous milestone," says Pneuma Systems Founder and CEO Jeffrey Carlisle. "Not just for Pneuma, but for the infusion pump industry and, most importantly, for patients and nurses everywhere."
Exit mobile version